Skip to main content
. 2020 Sep;8(17):1059. doi: 10.21037/atm-20-1007a

Figure 2.

Figure 2

Risk of bias assessment for indicated outcomes. Risk of bias was assessed by version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2). FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment of insulin resistance; SCFA, short-chain fatty acid.